A significant proportion of patients with acute coronary syndromes have undiagnosed diabetes or abnormal glucose metabolism, warranting aggressive screening.
May support glucose screening in ACS; leaves open effects on outcomes and management.
The current epidemic of obesity warrants aggressive screening for associated comorbid conditions; namely, the metabolic syndrome and diabetes mellitus. Approximately 25-30% of patients with acute coronary syndrome have diabetes. Of the remaining patients, most have a spectrum of abnormal glucose metabolism, including previously undiagnosed impaired fasting glucose and diabetes mellitus. This article reviews the current literature and the author's own experience of this subject, as well as highlighting effective new agents in treating diabetes.
No takes yet. Share an insight, caveat, or question.
Conaway et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: